Conference Coverage

Clues to rosacea in patients of skin of color


 

EXPERT ANALYSIS FROM THE 2017 AAD SUMMER MEETING

NEW YORK– A middle-aged patient with Fitzpatrick type V skin comes to the office with a 10-year history of “breakouts” on her face. When asked about topical treatments, she reports that “everything burns or stings,” and says she just has very sensitive skin. What could this be?

Dr. Andrew Alexis

Dr. Andrew Alexis

The first thought might not be rosacea in this darker-skinned woman, who shows little appreciable erythema on her face. However, according to Andrew Alexis, MD, dermatologists should move rosacea a little higher up the differential list in such cases.

Rosacea may often be missed in skin of color, said Dr. Alexis, speaking at the summer meeting of the American Academy of Dermatology. “It’s reportedly rare in darker skin types, especially in blacks,” and as a result, dermatologists and patients alike have a low index of suspicion for the diagnosis, he noted.

Also, rosacea looks different on darker skin than it does on lighter skin, which is featured in much of the dermatology teaching material. “In richly pigmented [Fitzpatrick] type VI skin, the erythema of rosacea can be masked,” said Dr. Alexis, chairman of the department of dermatology at Mount Sinai St. Luke’s and at Mount Sinai West, both in New York.

Dermatologists, in this case, may have to do some detective work: looking at the distribution of the lesions, thinking about trigger factors from the patient history, and noting the lack of comedones – although the patient has “pimples.” Patient complaints that they are sensitive to almost all topical products and experience stinging with “everything” is another very good clue that the patient may have rosacea.

Keep rosacea on the differential for this picture, advised Dr. Alexis. In skin of color, “rosacea may not be as rare as previously thought – less common, maybe – but not rare.”

Dr. Alexis reported financial relationships with multiple pharmaceutical companies.

On Twitter @karioakes

Recommended Reading

Expert shares new insights on the pathophysiology of rosacea
MDedge Family Medicine
Combined OCs remain a good choice for teen acne
MDedge Family Medicine
Ocular rosacea remains a stubborn foe
MDedge Family Medicine
‘Anxiety sensitivity’ tied to psychodermatologic disorders
MDedge Family Medicine
A sweet new solution for rosacea
MDedge Family Medicine
FDA approves topical oxymetazoline for rosacea
MDedge Family Medicine
VIDEO: Oxymetazoline approval expands options for rosacea
MDedge Family Medicine
Rosacea research reveals advances, promising therapies
MDedge Family Medicine
Some data support botulinum toxin for psoriasis and rosacea
MDedge Family Medicine
Dermatologist calls for paradigm shift on treating ocular rosacea
MDedge Family Medicine